MCP Tips for better browsing
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/mcp.M500090-MCP200 on June 20, 2005.
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
M500090-MCP200v1
4/12/1849    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Glossary
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Perluigi, M.
Right arrow Articles by Butterfield, D. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Perluigi, M.
Right arrow Articles by Butterfield, D. A.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Molecular & Cellular Proteomics 4:1849-1861, 2005.
© 2005 by The American Society for Biochemistry and Molecular Biology, Inc.


Research

Proteomic Analysis of Protein Expression and Oxidative Modification in R6/2 Transgenic Mice

A Model of Huntington Disease*

Marzia Perluigia,b, H. Fai Poonb, William Maragosc,d, William M. Piercee, Jon B. Kleinf, Vittorio Calabreseg, Chiara Cinia, Carlo De Marcoa and D. Allan Butterfieldb,h,i,j

From the aDepartment of Biochemical Sciences, University of Rome "La Sapienza," 00185 Rome, Italy, bDepartment of Chemistry, University of Kentucky, Lexington, Kentucky 40506-0055, cDepartment of Neurology, dAnatomy and Neurobiology, University of Kentucky, Lexington, Kentucky 40536-0305, eKidney Disease Program and Core Proteomics Laboratory and fDepartment of Pharmacology, University of Louisville School of Medicine and Veterans Affairs Medical Center, Louisville, Kentucky 40292, gDepartment of Chemistry, Section of Biochemistry, University of Catania, 95100 Catania, Italy, hCenter of Membrane Sciences, University of Kentucky, Lexington, Kentucky 40506-0059, and iSanders-Brown Center on Aging, University of Kentucky, Lexington, Kentucky 40536

Huntington disease (HD) is a hereditary neurodegenerative disorder characterized by motor, psychiatric, and cognitive symptoms. The genetic defect responsible for the onset of the disease, expansion of CAG repeats in exon 1 of the gene that codes for huntingtin on chromosome 4, has been unambiguously identified. On the other hand, the mechanisms by which the mutation causes the disease are not completely understood yet. However, defects in energy metabolism of affected cells may cause oxidative damage, which has been proposed as one of the underlying molecular mechanisms that participate in the etiology of the disease. In our effort to investigate the extent of oxidative damage occurring at the protein level, we used a parallel proteomic approach to identify proteins potentially involved in processes upstream or downstream of the disease-causing huntingtin in a well established HD mouse model (R6/2 transgenic mice). We have demonstrated that the expression levels of dihydrolipoamide S-succinyltransferase and aspartate aminotransferase increase consistently over the course of disease (10-week-old mice). In contrast, pyruvate dehydrogenase expression levels were found to be decreased in 10-week-old HD transgenic mice compared with young (4-week-old) mice. Our experimental approach also led to the identification of oxidatively modified proteins. Six proteins were found to be significantly oxidized in old R6/2 transgenic mice compared with either young transgenic mice or non-transgenic mice. These proteins are {alpha}-enolase, {gamma}-enolase (neuron-specific enolase), aconitase, the voltage-dependent anion channel 1, heat shock protein 90, and creatine kinase. Because oxidative damage has proved to play an important role in the pathogenesis and the progression of Huntington disease, our results for the first time identify specific oxidatively modified proteins that potentially contribute to the pathogenesis of Huntington disease.


jTo whom correspondence should be addressed: Dept. of Chemistry, Center of Membrane Sciences, and Sanders-Brown Center on Aging, University of Kentucky, Lexington, KY 40506-0055. Tel.: 859-257-3184; Fax: 859-257-5876; E-mail: dabcns{at}uky.edu


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
J. N. Savas, A. Makusky, S. Ottosen, D. Baillat, F. Then, D. Krainc, R. Shiekhattar, S. P. Markey, and N. Tanese
Huntington's disease protein contributes to RNA-mediated gene silencing through association with Argonaute and P bodies
PNAS, August 5, 2008; 105(31): 10820 - 10825.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
A. Zourlidou, T. Gidalevitz, M. Kristiansen, C. Landles, B. Woodman, D. J. Wells, D. S. Latchman, J. de Belleroche, S. J. Tabrizi, R. I. Morimoto, et al.
Hsp27 overexpression in the R6/2 mouse model of Huntington's disease: chronic neurodegeneration does not induce Hsp27 activation
Hum. Mol. Genet., May 1, 2007; 16(9): 1078 - 1090.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. ProteomicsHome page
M.-C. Chiang, C.-G. Juo, H.-H. Chang, H.-M. Chen, E. C. Yi, and Y. Chern
Systematic Uncovering of Multiple Pathways Underlying the Pathology of Huntington Disease by an Acid-cleavable Isotope-coded Affinity Tag Approach
Mol. Cell. Proteomics, May 1, 2007; 6(5): 781 - 797.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. Easlon, F. Tsang, I. Dilova, C. Wang, S.-P. Lu, C. Skinner, and S.-J. Lin
The Dihydrolipoamide Acetyltransferase Is a Novel Metabolic Longevity Factor and Is Required for Calorie Restriction-mediated Life Span Extension
J. Biol. Chem., March 2, 2007; 282(9): 6161 - 6171.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Journal of Biological Chemistry 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2005 by the American Society for Biochemistry and Molecular Biology.